PrP antibody binding-induced epitope modulation evokes immunocooperativity

Journal of Neuroimmunology

Volumn 205, Issue 1-2, 2008, Pages 94-100

  Chang, Binggong ^a   Miller, Michael W ^b   Bulgin, Marie S ^c   Sorenson Melson, Sharon ^c   Balachandran, Aru ^d   Chiu, Allen ^a   Rubenstein, Richard ^a  

^a SUNY Downstate Medical Center   (United States)

^b NATIONAL WILDLIFE RESEARCH CENTER   (United States)

^c UNIVERSITY OF IDAHO   (United States)

^d CANADIAN FOOD INSPECTION AGENCY   (Canada)

Author keywords

Epitope recognition; Immunocooperativity; Monoclonal antibodies; Prion protein

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; PRION PROTEIN ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; DEER; HAMSTER; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DENATURATION; SHEEP;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; BIOTINYLATION; BLOTTING, WESTERN; BRAIN; CRICETINAE; DEER; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; PRPC PROTEINS; SCRAPIE; SHEEP; WASTING DISEASE, CHRONIC;

EID: 56349171698     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.09.013     Document Type: Article

References (59)

1. Abid K., and Soto C. Biomedicine and diseases: review the intriguing prion disorders. Cell. Mol. Life Sci. 63 (2006) 2342-2351
2. Alonso D.O.V., DeArmond S.J., Cohen F.E., and Daggett V. Mapping the early steps in the pH-induced conformational conversion of the prion protein. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 2985-2989
3. Alonso D.O.V., An C., and Daggett V. Simulations of biomolecules: characterization of the early steps in the pH-induced conformational conversion of the hamster, bovine, and human forms of the prion protein. Philos. Trans. R. Soc. Lond., A 360 (2002) 1-13
4. Barnard G., and Sy M.S. The diagnosis of transmissible spongiform encephalopathies using differential extraction and DELFIA. In: Krull I. (Ed). Prions and Mad Cow Disease (2003), Marcel Dekker, New York 277-315
5. Basler K., Oesch B., Scott M., Westaway D., Wälchli M., Groth D.F., McKinley M.P., Prusiner S.B., and Weissmann C. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46 (1986) 417-428
6. Brown P., Liberski P.P., Wolff A., and Gajdusek D.C. Conservation of infectivity in purified fibrillary extracts of scrapie-infected hamster brain after sequential enzymatic digestion or polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 7240-7244
7. Brown K.L., Stewart K., Ritchie D.L., Mabbott N.A., Williams A., Fraser H., Morrison W.I., and Bruce M.E. Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nat. Med. 5 (1999) 1308-1312
8. Carp R.I., and Callahan S.M. In vitro interaction of scrapie agent and mouse peritoneal macrophages. Intervirology 16 (1981) 8-13
9. Carp R.I., Kim Y.S., and Callahan S.M. Pancreatic lesions and hypoglycemia-hyperinsulinemia in scrapie-infected hamsters. J. Infect. Dis. 161 (1990) 462-466
10. Caughey B. Interactions between prion protein isoforms: the kiss of death?. Trends Biochem. Sci. 26 (2001) 235-242
11. Caughey B., and Raymond G.J. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J. Biol. Chem. 266 (1991) 18217-18223
12. Caughey B., Raymond G.J., Ernst D., and Race R.E. N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s)-implications regarding the site of conversion of PrP to the protease-resistant state. J. Virol. 65 (1991) 6597-6603
13. Caughey B., Raymond G.J., Callahan M.A., Wong C., Baron G.S., and Xiong L. Interactions and conversions of prion protein isoforms. Adv. Protein Chem. 57 (2001) 139-169
14. Cohen F.E., and Prusiner S.B. Pathologic conformations of prion proteins. Ann. Rev. Biochem. 67 (1998) 793-819
15. Collins P.S., Lawson V.A., and Masters P.C. Transmissible spongiform encephalopathies. Lancet 363 (2004) 51-61
16. Cordeiro Y., Kraineva J., Gomes M.P.B., Lopes M.H., Martins V.R., Lima L.M.T.R., Foguel D., Winter R., and Silva J.L. The amino-terminal PrP domain is crucial to modulate prion misfolding and aggregation. Biophys. J. 89 (2005) 2667-2676
17. Dabaghian R.H., Barnard G., McConnell I., and Clewley J.P. An immunoassay for the pathological form of the prion protein based on denaturation and time resolved fluorometry. J. Virol. Methods 132 (2005) 85-91
18. Dickinson A.G., and Outram G.W. Genetic aspects of unconventional virue infections: the basis of the virino hypothesis. Ciba Found. Symp. 135 (1988) 63-83
19. Glatzel M., Ott P.M., Linder T., Gebbers J.O., Gmür A., Wüst W., Huber G., Moch H., Podvinec M., Stamm B., and Aguzzi A. Human prion diseases: epidemiology and integrated risk assessment. Lancet Neurol. 2 (2003) 757-763
20. Heikenwalder M., Zeller N., Seeger H., Prinz M., Klohn P.-C., Schwarz P., Ruddle N.H., Weissmann C., and Aguzzi A. Chronic lymphocytic inflammation specifies the organ tropism of prions. Science 307 (2005) 1107-1110
21. Hilmert H., and Diringer H. A rapid and efficient method to enrich SAF-protein from scrapie brains of hamsters. Biosci. Rep. 4 (1984) 165-170
22. Horiuchi M., and Caughey B. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J. 18 (1999) 3193-3203
23. Horiuchi M., Chabry J., and Caughey B. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J. 18 (1999) 3193-3203
24. Horiuchi M., Baron G.S., Xiong L.-W., and Caughey B. Inhibition of interactions and interconversions of prion protein isoforms by peptide fragments from the C-terminal folded domain. J. Biol. Chem. 276 (2001) 15489-15497
25. Jimenez R., Salazar G., Yin J., Joo T., and Romesberg F.E. Protein dynamics and the immunological evolution of molecular recognition. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 3803-3808
26. Kang S.-C., Li R., Wang C., Pan T., Liu T., Rubenstein R., Barnard G., Wong B.-S., and Sy M.-S. Guanidine hydrochloride extraction and detection of prion proteins in mouse and hamster prion diseases by ELISA. J. Pathol. 199 (2003) 534-541
27. Kascsak R.J., Rubenstein R., Merz P.A., Carp R.I., Robakis N.K., Wisniewski H.M., and Diringer H. Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains. J. Virol. 59 (1986) 676-683
28. Kascsak R.J., Rubenstein R., Merz P.A., Tonna-DeMasi M., Fersko R., Carp R.I., Wisniewski H.M., and Diringer H. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J. Virol. 61 (1987) 3688-3693
29. Kim J.-I., Kuizon S., and Rubenstein R. Comparison of PrP transcription and translation in two murine myeloma cell lines. J. Neuroimmunol. 140 (2003) 137-142
30. Kitamoto T., Muramoto T., Mohri S., Doh-Ura K., and Tateishi J. Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease. J. Virol. 65 (1991) 6292-6295
31. Klein M.A., Kaeser P.S., Schwarz P., Weyd H., Xenarios I., Zinkernagel R.M., Carroll M.C., Verbeek J.S., Botto M., Walport M.J., Molina H., Kalinke U., Acha-Orbea H., and Aguzzi A. Complement facilitates early prion pathogenesis. Nat. Med. 7 (2001) 410-411
32. Kocisko D.A., Come J.H., Priola S.A., Chesebro B., Raymond G.J., Lansbury P.T., and Caughey B. Cell-free formation of protease-resistant prion protein. Nature 370 (1994) 471-474
33. Kocisko D.A., Priola S.A., Raymond G.J., Chesebro B., Lansbury Jr. P.T., and Caughey B. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 3923-3927
34. Korth C., Stierli B., Streit P., Moser M., Schaller O., Fischer R., Schulz-Schaeffer W., Kretzschmar H., Raeber A., Braun U., Ehrensperger F., Hornemann S., Glockshuber R., Riek R., Billeter M., Wüthrich K., and Oesch B. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature 390 (1997) 74-77
35. C. J. Gen. Virol. 87 (2006) 3773-3780
36. Li R., Liu T., Wong B.-S., Pan T., Morillas M., Swietnicki W., O'Rourke K., Gambetti P., Surewicz W.K., and Sy M.-S. Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. J. Mol. Biol. 301 (2000) 567-573
37. Manuelidis L. A 25 nm virion is the likely cause of transmissible spongiform encephalopathies. J. Cell. Biochem. 100 (2007) 897-915
38. Moroncini G., Kanu N., Solforosi L., Abalos G., Telling G.C., Head M., Ironside J., Brockes J.P., Burton D.R., and Williamson R.A. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10404-10409
39. Muramoto T., Scott M., Cohen F.E., and Prusiner S.B. Recombinant scrapie-like prion protein of 106 amino acids is soluble. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 15457-15462
40. Novitskaya V., Makarava N., Bellon A., Bocharova O.V., Bronstein I.B., Williamson R.A., and Baskakov I.V. Probing the conformation of the prion protein within a single amyloid fibril using a novel immunoconformational assay. J. Biol. Chem. 281 (2006) 15536-15545
41. Pan K.M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R.J., Cohen F.E., and Prusiner S.B. Conversion of -helices into ß-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 10962-10966
42. Pan T., Li R., Kang S.-C., Wong B.-S., Wisniewski T., and Sy M.-S. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion. J. Neurochem. 90 (2004) 1205-1217
43. Paramithiotis E., Pinard M., Lawton T., LaBoissiere S., Leathers V.L., Zou W.Q., Estey L.A., Lamontagne J., Lehto M.T., Kondejewski L.H., Francoeur G.P., Papadopoulos M., Haghighat A., Spatz S.J., Head M., Will R., Ironside J., O'Rourke K., Tonelli Q., Ledebur H.C., Chakrabartty A., and Cashman N.R. A prion protein epitope selective for the pathologically misfolded conformation. Nat. Med. 9 (2003) 893-899
44. Peretz D., Williamson R.A., Matsunaga Y., Serban H., Pinilla C., Bastidas R.B., Rozenshteyn R., James T.L., Houghten R.A., Cohen F.E., Prusiner S.B., and Burton D.R. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J. Mol. Biol. 273 (1997) 614-622
45. Prinz M., Heikenwalder M., Junt T., Schwarz P., Glatzel M., Heppner F.L., Fu Y.X., Lipp M., and Aguzzi A. Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature 425 (2003) 957-962
46. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 216 (1982) 136-144
47. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13363-13383
48. Rubenstein R., Carp R.I., Ju W., Scalici C., Papini M., Rubenstein A., and Kascsak R. Concentration and distribution of infectivity and PrPSc following partial denaturation of a mouse-adapted and a hamster-adapted scrapie strain. Arch. Virol. 139 (1994) 301-311
49. (Sc) molecules with different conformations. Nat. Med. 4 (1998) 1157-1165
50. Safar J.G., Scott M., Monaghan J., Deering C., Didorenko S., Vergara J., Ball H., Legname G., Leclerc E., Solforosi L., Serban H., Groth D., Burton D.R., Prusiner S.B., and Williamson R.A. Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat. Biotechnol. 20 (2002) 1147-1150
51. Safar J.G., Geschwind M.D., Deering C., Didorenko S., Sattavat M., Sanchez H., Serban A., Vey M., Baron H., Giles K., Miller B.L., DeArmond S.J., and Prusiner S.B. Diagnosis of human prion disease. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3501-3506
52. Saborio G.P., Permanne B., and Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature (London) 411 (2001) 810-813
53. Stahl N., and Prusiner S.B. Prions and prion proteins. FASEB J. 5 (1991) 2799-2807
54. Stahl N., Baldwin M.A., Teplow D.B., Hood L., Gibson B.W., Burlingame A.L., and Prusiner S.B. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 32 (1993) 1991-2002
55. Tayebi M., Enever P., Sattar Z., Collinge J., and Hawke S. Disease-associated prion protein elicits immunoglobulin M responses in vivo. Mol. Med. 10 (2004) 104-111
56. Torrent J., Alvarez-Martinez M.T., Liautard J.-P., Balny C., and Lange R. The role of the 132-160 region in prion protein conformational transitions. Protein Sci. 14 (2004) 956-967
57. Tzaban S., Friedlander G., Schonberger O., Horonchilk L., Yedidia Y., Shaked G., Gabizon R., and Taraboulos A. Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 41 (2002) 12868-12875
58. Wadsworth J.D.F., and Collinge J. Update on human prion disease. Biochim. Biophys. Acta 1772 (2007) 598-609
59. Yuan F.F., Biffin S., Brazier M.W., Suarez M., Roberto C.C., Hill A., Collins S.J., Sullivan J.S., Middleton D., Multhaup G., Geczy A.F., and Masters C.L. Detection of prion epitopes on PrPc and PrPsc of transmissible spongiform encephalopathies using specific monoclonal antibodies to PrP. Immunol. Cell Biol. 83 (2005) 632-637